Sabra Health Care REIT (SBRA) Stock Forecast & Price Target

$18.68

+0.46 (+2.52%)

(As of 10/18/2024 ET)

Sabra Health Care REIT - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 8 Analyst Ratings

Sell
0

Hold
1

Buy
7

Based on 8 Wall Street analysts who have issued ratings for Sabra Health Care REIT in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 1 has given a hold rating, and 7 have given a buy rating for SBRA.

Consensus Price Target

$18.38
-1.63% Downside

According to the 8 analysts' twelve-month price targets for Sabra Health Care REIT, the average price target is $18.38. The highest price target for SBRA is $21.00, while the lowest price target for SBRA is $16.00. The average price target represents a forecasted downside of -1.63% from the current price of $18.68.

SBRA Analyst Ratings Over Time

Type	Current Forecast 10/21/23 to 10/20/24	1 Month Ago 9/21/23 to 9/20/24	3 Months Ago 7/23/23 to 7/22/24	1 Year Ago 10/21/22 to 10/21/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	7 Buy rating(s)	8 Buy rating(s)	7 Buy rating(s)	4 Buy rating(s)
Hold	1 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)	6 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$18.38	$17.09	$16.09	$14.41
Forecasted Upside	-1.63% Downside	-8.31% Downside	-2.77% Downside	2.63% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Hold

Election warning coming true… (Ad)

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

SBRA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SBRA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Sabra Health Care REIT Stock vs. The Competition

Type	Sabra Health Care REIT	Finance Companies	S&P 500
Consensus Rating Score	2.88	2.48	2.50
Consensus Rating	Moderate Buy	Hold	Hold
Predicted Upside	-1.63% Downside	11.76% Upside	6.20% Upside
News Sentiment Rating	Positive News See Recent SBRA News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/11/2024	Scotiabank 5 of 5 stars		Boost Target	Sector Perform ➝ Sector Perform	$17.00 ➝ $18.00	+0.11%
10/1/2024	Wells Fargo & Company 3 of 5 stars	J. Feldman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$16.00 ➝ $20.00	+7.47%
9/13/2024	Citigroup 3 of 5 stars	N. Joseph Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Neutral ➝ Buy	$17.00 ➝ $20.00	+8.99%
9/4/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$16.00 ➝ $18.00	+4.23%
2/29/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform	$17.00	+22.92%
1/30/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$21.00	+55.79%
Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown” (Ad) Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now. Click here to see it because it’s a SHOCKER…
1/3/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$15.00 ➝ $17.00	+19.63%
11/7/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$14.00 ➝ $16.00	+14.94%
10/17/2023	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform ➝ Market Perform	$16.00	+9.89%
10/10/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Neutral ➝ Buy	$14.00 ➝ $16.00	+14.20%
9/20/2023	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Hold ➝ Buy	$11.00 ➝ $15.00	+12.28%
7/27/2023	Berenberg Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold	$13.00	-0.99%
4/25/2023	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$15.00 ➝ $13.00	+18.18%
4/12/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral	$13.00	+10.64%
12/13/2022	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:34 AM ET.

SBRA Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Sabra Health Care REIT is $18.38, with a high forecast of $21.00 and a low forecast of $16.00.
: 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last year. There is currently 1 hold rating and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SBRA shares.
: According to analysts, Sabra Health Care REIT's stock has a predicted downside of -1.63% based on their 12-month stock forecasts.
: Over the previous 90 days, Sabra Health Care REIT's stock had 2 upgrades by analysts.
: Sabra Health Care REIT has been rated by research analysts at Citigroup, Scotiabank, Truist Financial, and Wells Fargo & Company in the past 90 days.
: Analysts like Sabra Health Care REIT more than other "finance" companies. The consensus rating for Sabra Health Care REIT is Moderate Buy while the average consensus rating for "finance" companies is Hold. Learn more on how SBRA compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

The real reason Elon is fully endorsing Trump (Ad)

Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump.

Watch this new documentary and you’ll discover what Elon knows,

This page (NASDAQ:SBRA) was last updated on 10/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings

Sabra Health Care REIT (SBRA) Stock Forecast & Price Target